Citation Formats
Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. B. DİRİM Et Al. , "Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis," 56th ERA-EDTA Congress , vol.34, Budapest, Hungary, pp.422, 2019

DİRİM, A. B. Et Al. 2019. Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis. 56th ERA-EDTA Congress , (Budapest, Hungary), 422.

DİRİM, A. B., MİRİOĞLU, Ş., DEMİR, E., ÖZLÜK, M. Y., ÇALIŞKAN, Y. K., YAZICI, H., ... KILIÇASLAN, I.(2019). Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis . 56th ERA-EDTA Congress (pp.422). Budapest, Hungary

DİRİM, AHMET Et Al. "Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis," 56th ERA-EDTA Congress, Budapest, Hungary, 2019

DİRİM, AHMET B. Et Al. "Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis." 56th ERA-EDTA Congress , Budapest, Hungary, pp.422, 2019

DİRİM, A. B. Et Al. (2019) . "Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis." 56th ERA-EDTA Congress , Budapest, Hungary, p.422.

@conferencepaper{conferencepaper, author={AHMET BURAK DİRİM Et Al. }, title={Efficacy of Eculizumab in Patients with Refractory C3 Glomerulonephritis}, congress name={56th ERA-EDTA Congress}, city={Budapest}, country={Hungary}, year={2019}, pages={422} }